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Background
Published studies have revealed protective actions of high
levels of natriuretic peptides on vascular regeneration in
response to ischemia. BNP overexpressed systemically in
transgenic mice or gene transfer of CNP into ischemic
muscles effectively accelerates angiogenesis [1]. These
studies suggest that pharmacological levels of exogenous
NPs might be used as a strategy of therapeutic angiogen-
esis. However, they do not reveal whether endogenous NPs
exert (patho-) physiological vasculoprotective actions. To
investigate this question, we studied the impact of genetic
ablation of guanylyl cyclase-A (GC-A), the receptor for
ANP and BNP, on postocclusive hindlimb ischemia in
mice.
Methods
The right femoral artery and vein were excised under
anesthesia. A Laser Doppler Perfusion Imager (LDPI) was
used to estimate relative blood flow during seven weeks
following surgery. These functional in vivo studies were
complemented with studies on cultured primary murine
lung endothelial cells (MLEC).
Results and conclusion
Serial blood flow measurements by LDPI revealed that
postocclusive hindlimb perfusion was severly impaired in
mice with global GC-A deletion (GC-A-/-) as compared to
respective WT mice. The calculated perfusion ratio of
ischemic to nonischemic hindlimb was 0.15 ± 0.02 for
WT vs. 0.09 ± 0.007 for GC-A-/- mice at day 3 (P = 0.02).
After 35 days, restoration of perfusion in GC-A-/- mice
was still drastically reduced demonstrating that endog-
enous NPs, via GC-A, exert important vasculoprotective
actions. To dissect the specific vascular cell type mediating
this effect, we took advantage of two genetic mouse lines
with conditional, cell-restricted deletion of GC-A either in
smooth muscle (SMC GC-A KO) or in endothelial cells
(EC GC-A KO), both previously generated in our labora-
tory [2,3]. In SMC GC-A KO mice the extent of restoration
of perfusion at any time point was close to control litter-
mates. In contrast, in EC GC-A KO mice postocclusive
hindlimb perfusion was severely impaired during the
whole observation period.
Incubation of cultured MLEC with ANP increased intrac-
ellular cGMP, activity of cGMP-dependent protein kinase
I (PKG I) and phosphorylation of the extracellular signal
regulated kinase ERK1/2. These responses were com-
pletely abolished in GC-A-deficient MLEC.
We conclude that endogenous ANP and/or BNP exert crit-
ical endothelium-mediated vasculoprotective effects after
arterial occlusion. Our future studies will be directed to
elucidate whether these effects are related to (PKG I, ERK-
from 3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications
Dresden, Germany. 15–17 June 2007
Published: 25 July 2007
BMC Pharmacology 2007, 7(Suppl 1):S17 doi:10.1186/1471-2210-7-S1-S17
<supplement> <title> <p>3<sup>rd </sup>International Conference on cGMP Generators, Effectors and Therapeutic Implications</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2210-7-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.biomedcentral.com/1471-2210/7/S1/S17
© 2007 Kuhn et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
BMC Pharmacology 2007, 7(Suppl 1):S17 http://www.biomedcentral.com/1471-2210/7/S1/S17Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
dependent?) endothelial regeneration and angiogenesis
or to endothelium-dependent vasodilatation.
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